| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Restricted Stock Units | 1,509,790 | $1,011,559 | $0.6700 | 13 Feb 2025 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 2,264,690 | 13 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 13 Feb 2025 | 2 | $0 | 4 | Chief Executive Officer, Director | 18 Feb 2025, 16:16 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 08 Jul 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 08 Jul 2024, 17:27 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 08 Jul 2024 | 0 | $0 | 3 | Chief Executive Officer, Director | 08 Jul 2024, 17:26 |